Cross-SectionalModerate Evidence2019

Your dispensary's strain names are genetically unreliable

Genetic tools weed out misconceptions of strain reliability in Cannabis sativa: implications for a budding industry.

Schwabe, Anna L; McGlaughlin, Mitchell E·Journal of cannabis research·PubMed

Bottom Line

Genetic analysis of 30 commercially available cannabis strains found no clear genetic distinction between sativa, indica, and hybrid types, and significant genetic inconsistencies within strains from different dispensaries.

Why It Matters

Millions of consumers choose products based on sativa/indica labels, believing they predict effects. This study shows those labels have no genetic foundation, meaning consumers may be making decisions based on unreliable information.

The Backstory

Walk into a dispensary in Denver and buy a gram of Sour Diesel. Fly to Seattle and buy Sour Diesel from a shop there. Drive to Los Angeles and buy it again. You have three products with the same name, from three legal markets, presumably the same strain.

Anna Schwabe ran the DNA. They were not the same plant.

In 2019, Schwabe and Mitchell McGlaughlin from the University of Northern Colorado published the first genetic study to directly test whether cannabis strain names mean what consumers think they mean. They purchased 122 samples of 30 strains from 20 dispensaries across Colorado, California, and Washington, developed new genetic markers, and asked the simplest possible question: when two shops sell "Blue Dream," are they selling the same thing?

The answer, for many strains, was no.

Why Nobody Had Tested This Before

2019·University of Northern Colorado, Greeley, CO

Cannabis occupies a unique regulatory void. Unlike virtually every other commercially grown plant in the United States, it is excluded from USDA regulation. Distinctive cannabis varieties cannot be registered through the standard Plant Variety Protection system. There is no national catalog of verified genetic identities for cannabis strains, no certification body, and no verification requirement.

For every other crop — tomatoes, apples, wheat, roses — the agricultural system includes formal variety registration, breeder's rights protections, and genetic verification. If you buy a Honeycrisp apple tree, it is genetically a Honeycrisp apple tree. The system enforces this.

Cannabis has none of that infrastructure. Strain names are assigned by growers, inherited through clonal propagation and seed trading, and passed along through an underground market that predates legalization by decades. There was never a catalog, never a registry, and once the legal market opened, no one built one. Schwabe and McGlaughlin decided to test what that absence had produced.

The Methodology

What They Found

The results tell two stories — one alarming, one partially reassuring.

2,000+

named cannabis strains are commercially available, but no standardized genetic verification system exists. This study tested 30 — fewer than 2% — and found widespread inconsistency. When 'Golden Goat' from one dispensary is more genetically similar to 'Island Sweet Skunk' than to another shop's 'Golden Goat,' the naming system is functionally broken for cross-source comparisons.

Compare this to wine, where appellation systems, grape variety registries, and regulatory oversight mean that a bottle labeled 'Pinot Noir' from any producer will actually contain Pinot Noir grapes. Cannabis has no equivalent.

Schwabe & McGlaughlin (2019)

Why This Matters for Consumers

For recreational users, strain inconsistency means unexpected experiences. You tried Blue Dream once, liked it, and bought it again from a different shop — but the genetics are different, the terpene profile is different, and the experience is different. Annoying, but manageable.

For medical patients, the implications are more serious. Patients who find a strain that reliably alleviates specific symptoms — chronic pain, insomnia, nausea — depend on consistency. If the "Harlequin" they buy this month is genetically unrelated to the "Harlequin" that worked last month, their treatment becomes unpredictable.

The Bigger Picture: No Verification System

Schwabe's study didn't just document a problem — it highlighted a structural absence. Every other legal agricultural product in the United States has some form of variety verification. Cannabis, because of its federal scheduling and the speed with which state-level legalization outpaced regulatory infrastructure, has none.

The result is a naming system that evolved from underground culture, was adopted wholesale by the legal market, and has never been scientifically validated. Strain names carry cultural meaning, marketing value, and consumer expectations — but they do not carry genetic guarantees.

This finding connects directly to Piomelli and Russo's 2016 argument that the indica/sativa framework is "total nonsense." Schwabe's data shows it is worse than that: even within the strain-name system, consistency is not assured. The indica/sativa labels are unreliable, and the strain names within those categories are also unreliable.

The Watts et al. 2021 study in Nature Plants later confirmed Schwabe's findings with an even larger genomic dataset: sativa and indica labels are genetically indistinct on a genome-wide scale, with the only consistent association being terpene synthase genes that influence aroma — the labels track smell, not pharmacology.

Myth vs. Reality

Myth

If I buy the same strain name from any dispensary, I'm getting the same product.

Reality

Genetic analysis of 30 strains across 20 dispensaries in three states found that most strains contained at least one genetic outlier. Two samples of 'Sour Diesel' from different sources were less genetically similar than samples of 'Golden Goat' and 'Island Sweet Skunk.' Strain names are reasonably reliable within a single grower but unreliable across the industry.

The Evidence

Schwabe & McGlaughlin (2019): 122 samples, 30 strains, 20 dispensaries, Colorado/California/Washington. De novo microsatellite marker analysis.

Schwabe & McGlaughlin (2019), J Cannabis Research 1(1):3

Frequently Asked Questions

Genetic tools weed out misconceptions of strain reliability in Cannabis sativa: implications for a budding industry

Schwabe AL, McGlaughlin ME () · Journal of Cannabis Research

Cite this study

Schwabe, Anna L; McGlaughlin, Mitchell E. (2019). Genetic tools weed out misconceptions of strain reliability in Cannabis sativa: implications for a budding industry.. Journal of cannabis research, 1(1), 3. https://doi.org/10.1186/s42238-019-0001-1

Related Research

RTHC-02933Narrative ReviewPreliminary Evidence2020RETHINKTHC RESEARCH DATABASErethinkthc.com/researchRTHC-06775Quasi ExperimentalModerate Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/researchRTHC-01203Cross SectionalPreliminary Evidence2016RETHINKTHC RESEARCH DATABASErethinkthc.com/researchRTHC-01523Retrospective CohortStrong Evidence2017RETHINKTHC RESEARCH DATABASErethinkthc.com/research